RLY5016

Relypsa's current drug candidates are based on tailored non-absorbed polymers, where the polymer itself provides the drug function. By preventing degradation and systemic uptake, the polymeric drugs are designed to act in the gastrointestinal tract and clear the human body through the digestive system. These non-absorbed features lead to potentially improved safety profiles.